BRPI0818844A2 - Métodos de inibição de infecção viral. - Google Patents

Métodos de inibição de infecção viral.

Info

Publication number
BRPI0818844A2
BRPI0818844A2 BRPI0818844A BRPI0818844A2 BR PI0818844 A2 BRPI0818844 A2 BR PI0818844A2 BR PI0818844 A BRPI0818844 A BR PI0818844A BR PI0818844 A2 BRPI0818844 A2 BR PI0818844A2
Authority
BR
Brazil
Prior art keywords
methods
viral infection
inhibiting viral
inhibiting
infection
Prior art date
Application number
Other languages
English (en)
Inventor
Michael Kinch
Michael Goldblatt
Original Assignee
Functional Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Functional Genetics Inc filed Critical Functional Genetics Inc
Publication of BRPI0818844A2 publication Critical patent/BRPI0818844A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/131Amines acyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0818844 2007-10-24 2008-10-23 Métodos de inibição de infecção viral. BRPI0818844A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98222707P 2007-10-24 2007-10-24
PCT/US2008/080867 WO2009055524A1 (en) 2007-10-24 2008-10-23 Methods of inhibiting viral infection

Publications (1)

Publication Number Publication Date
BRPI0818844A2 true BRPI0818844A2 (pt) 2015-04-22

Family

ID=40579993

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818844 BRPI0818844A2 (pt) 2007-10-24 2008-10-23 Métodos de inibição de infecção viral.

Country Status (12)

Country Link
US (1) US8207209B2 (pt)
EP (1) EP2207801B1 (pt)
JP (1) JP2011500830A (pt)
CN (1) CN101952310A (pt)
AU (1) AU2008316890A1 (pt)
BR (1) BRPI0818844A2 (pt)
CA (1) CA2702248A1 (pt)
IL (1) IL205035A0 (pt)
MX (1) MX2010004361A (pt)
RU (1) RU2010120686A (pt)
WO (1) WO2009055524A1 (pt)
ZA (1) ZA201002549B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110152343A1 (en) * 2009-12-22 2011-06-23 Functional Genetics, Inc. Protease inhibitors and broad-spectrum antiviral
EP2770993A2 (en) 2011-10-26 2014-09-03 The United States of America, as represented by The Secretary, Department of Health and Human Services Method of treating hcv infection with a small molecule chk2 inhibitor
WO2013069780A1 (ja) * 2011-11-11 2013-05-16 出光興産株式会社 ウイルス感染防除剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324794A (en) * 1980-08-26 1982-04-13 Research Triangle Institute Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds
JP3457694B2 (ja) * 1993-02-04 2003-10-20 第一製薬株式会社 インフルエンザ感染予防・治療薬
US6815461B1 (en) * 1994-01-20 2004-11-09 The University Of North Carolina At Chapel Hill Method of inhibiting retroviral integrase
JP4021484B2 (ja) 1995-11-16 2007-12-12 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 腫瘍の表現型を特徴付けする方法
US6916917B1 (en) * 1998-11-17 2005-07-12 California Institute Of Technology Chimeric pro-caspases and methods of using same
AU1450401A (en) * 1999-11-01 2001-05-14 Auburn University Methods and formulations for the treatment of infectious bursal disease in avian subjects
US20060111312A1 (en) * 2002-02-22 2006-05-25 The John Hopkins University Antigene locks and therapeutic uses thereof
US7427468B2 (en) 2002-10-01 2008-09-23 Functional Genetics, Inc. Anti-TSG101 antibodies and their uses for treatment of viral infections
WO2005055935A2 (en) * 2003-12-05 2005-06-23 The University Of North Carolina At Chapel Hill Cationic substituted benzofurans as antimicrobial agents
US20060142259A1 (en) * 2004-06-25 2006-06-29 Limin Li Compounds, pharmaceutical compositions and methods for inhibiting HIV infectivity
EP1945209B1 (en) * 2005-08-12 2018-05-30 United States Government As Represented By The Secretary of The United States Army And The U.S. Army Medical Research & Materiel Command Broad spectrum antibacterial compounds
CA2672290A1 (en) * 2007-01-15 2008-07-24 The United States Of America, As Represented By The Secretary Of The Arm Y, On Behalf Of The U.S. Army Research Institute Of Infectious Diseases Antiviral compounds and methods of using thereof

Also Published As

Publication number Publication date
JP2011500830A (ja) 2011-01-06
EP2207801A4 (en) 2011-03-23
US20090170890A1 (en) 2009-07-02
EP2207801B1 (en) 2013-04-17
RU2010120686A (ru) 2011-11-27
CA2702248A1 (en) 2009-04-30
AU2008316890A1 (en) 2009-04-30
MX2010004361A (es) 2010-09-10
CN101952310A (zh) 2011-01-19
WO2009055524A1 (en) 2009-04-30
EP2207801A1 (en) 2010-07-21
IL205035A0 (en) 2010-11-30
WO2009055524A8 (en) 2010-08-26
US8207209B2 (en) 2012-06-26
ZA201002549B (en) 2011-06-29

Similar Documents

Publication Publication Date Title
DK2084174T3 (da) Fremstilling af ribofuranosylpyrimidinnukleotider
EP2509639A4 (en) DISINFECTION SYSTEM FOR HARD SURFACES
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
BRPI1010506A2 (pt) "inibidores do vírus da hepatite c"
ATE450271T1 (de) Impfstoff
EP2124523A4 (en) BREEDING LINE P2428-5006090
BRPI0817444A2 (pt) Prímeres de poliunucleotídeo
BR112012000735A2 (pt) "métodos, kits e conjuntos de compostos"
DK2114993T3 (da) Vaccine
DK2200554T3 (da) Ganghjælpemiddel
BRPI0923497A2 (pt) derivados de piridazinona
EP1984323A4 (en) VIRAL POLYMERASE INHIBITORS
BRPI0821342A2 (pt) inibidores da polimerase viral
BRPI0813681A2 (pt) Detecção de coproantígeno de nematelminto
BRPI0821034A2 (pt) Vírus influenza modificado
EP2110789A4 (en) PAPER MONEY PROCESSOR
BRPI0909422A2 (pt) conjunto de artigos.
DK2173831T3 (da) Brøndbehandling
DK3006038T3 (da) Enkeltdoser af oritavancin til behandling eller forebyggelse af en bakterieinfektion
BRPI0912547A2 (pt) aba de fixação
BRPI1008674A2 (pt) Métodos de redução do desenvolvimento de pragas resistentes.
EP2054388A4 (en) VIRAL POLYMERASE INHIBITORS
BRPI1013768A2 (pt) "proteção de câmaras de amostras bioanalíticas."
BRPI0917522A2 (pt) Protetores de cultura
DK2158334T3 (da) Detektion af methicillin-resistent staphylococcus

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.